East Texas is at the forefront of cardiac care as the Heart Institute of East Texas, in association with CHI St. Luke’s Memorial Hospital, introduces Pulse Field Ablation (PFA) therapy for atrial fibrillation (AFib).
Dr. Subramanya Gajaraju Venkata, an electrophysiologist and interventional cardiologist with the Heart Institute, successfully performed the first PFA procedure in Lufkin, marking a new era in electrophysiology. The procedure utilized the Farapulse PFA system by Boston Scientific, a significant advancement in the treatment of AFib.
AFib is a common heart rhythm disorder that affects millions worldwide, causing symptoms like palpitations, shortness of breath and fatigue, while increasing the risk of stroke and heart failure. PFA offers a safer and more efficient alternative to traditional ablation methods.
“The introduction of PFA technology marks a new era in electrophysiology,” Venkata said. “This groundbreaking technology uses ultra short-pulsed field energy which selectively targets and ablates cardiac tissue without damaging surrounding structures. This precision allows for a reduced risk of complications associated with traditional AFib ablation methods and shorter procedure times, leading to safer and quicker recovery. This continues to aide our mission of keeping care local so that patients don’t have to travel to larger cities for advanced cardiac care.”
Dr. Ravinder Bachireddy, Chief of Cardiology at CHI St. Luke’s Memorial Hospital, echoed this sentiment, stating, “The introduction of Pulsed Field Ablation at our hospital is a major step forward in cardiac care. This technology enables us to provide the highest level of care to our patients right here in Lufkin.”
The Heart Institute of East Texas remains committed to providing the latest and most effective treatments for heart conditions. The introduction of Pulsed Field Ablation at CHI St. Luke’s Memorial is a testament to their dedication to advancing cardiac care in the community.
